Published in Acta Endocrinol (Copenh) on February 01, 1989
Galactose toxicity in animals. IUBMB Life (2009) 1.19
Gonadal function in galactosemics and in galactose-intoxicated animals. Eur J Pediatr (1995) 0.89
ARHI: A new target of galactose toxicity in Classic Galactosemia. Biosci Hypotheses (2008) 0.79
Pregnancy after age 50: application of oocyte donation to women after natural menopause. Lancet (1993) 3.60
Does prayer influence the success of in vitro fertilization-embryo transfer? Report of a masked, randomized trial. J Reprod Med (2001) 3.29
Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2001) 3.03
Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis (1990) 2.68
Reversing the natural decline in human fertility. An extended clinical trial of oocyte donation to women of advanced reproductive age. JAMA (1992) 2.29
Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet (1989) 2.20
Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05
Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. Climacteric (2013) 1.94
Correlation of ovarian function with galactose-1-phosphate uridyl transferase levels in galactosemia. J Pediatr (1988) 1.79
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77
A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med (1990) 1.76
Global consensus statement on menopausal hormone therapy. Climacteric (2013) 1.74
Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol (1982) 1.66
Factors affecting embryo implantation after human in vitro fertilization: a hypothesis. Am J Obstet Gynecol (1990) 1.64
Menopausal hot flushes and night sweats: where are we now? Climacteric (2011) 1.61
Diagnosis and management of a tuberculous, tuboappendiceal fistula. Am J Obstet Gynecol (1988) 1.60
Management of unruptured ectopic gestation by linear salpingostomy: a prospective, randomized clinical trial of laparoscopy versus laparotomy. Obstet Gynecol (1989) 1.60
The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertil Steril (1994) 1.51
Why delay the obvious need for milder forms of ovarian stimulation? Hum Reprod (1997) 1.50
Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med (1981) 1.47
Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric (2011) 1.47
Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J Cardiovasc Transl Res (2009) 1.47
Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation. Fertil Steril (1995) 1.42
Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab (1999) 1.42
Therapeutic controversy: Estrogen replacement in menopause. J Clin Endocrinol Metab (1996) 1.41
Identifying hearing loss in the intensive care nursery: a 20-year summary. J Am Acad Audiol (1994) 1.41
Simultaneous establishment of pregnancies in two ovarian failure patients using one oocyte donor. Fertil Steril (1989) 1.39
Deletion of the short arm of chromosome no.9 (46,9p-): a new deletion syndrome. Ann Genet (1973) 1.38
Embryo implantation after human in vitro fertilization: importance of endometrial receptivity. Fertil Steril (1990) 1.37
Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? Am J Obstet Gynecol (1992) 1.37
The Frizzled CRD domain is conserved in diverse proteins including several receptor tyrosine kinases. Curr Biol (1998) 1.35
A randomized comparison of nonoral estradiol delivery in postmenopausal women. Am J Obstet Gynecol (1988) 1.28
The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention. Br J Cancer (1987) 1.27
Idiopathic hypoglycemia: a study of twenty-six children. J Pediatr (1969) 1.26
Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril (1994) 1.21
Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod (1997) 1.20
Propionic acidemia in patients with ketotic hyperglycinemia. J Pediatr (1971) 1.20
Identification of a case of Y:18 translocation using a Y-specific repetitive DNA probe. Hum Genet (1985) 1.20
Peripheral joint laxity increases in pregnancy but does not correlate with serum relaxin levels. Am J Obstet Gynecol (1996) 1.17
Factors affecting pregnancy success of human in-vitro fertilization in unstimulated cycles. Hum Reprod (1994) 1.16
In vitro fertilization in unstimulated cycles: the University of Southern California experience. Fertil Steril (1992) 1.16
Hemolytic-uremic syndrome. Clinical and pathological considerations. N Engl J Med (1966) 1.15
Deficit of uridine diphosphate galactose in galactosaemia. J Inherit Metab Dis (1989) 1.14
Etiology of supracondylar humerus fractures. J Pediatr Orthop (1998) 1.14
Oocyte donation to women of advanced reproductive age: pregnancy results and obstetrical outcomes in patients 45 years and older. Hum Reprod (1996) 1.13
Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis. Am J Obstet Gynecol (1993) 1.13
The 9p- syndrome. Ann Genet (1976) 1.12
Re-evaluating the role of progestogen therapy after the menopause. Fertil Steril (1988) 1.12
Biochemical and molecular studies of 132 patients with galactosemia. Hum Genet (1994) 1.12
Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters. J Clin Endocrinol Metab (2005) 1.10
Thrombosis, nephrosis, and corticosteroid therapy. J Pediatr (1968) 1.10
Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc Gynecol Investig (1998) 1.09
Verbal dyspraxia in treated galactosemia. Pediatrics (1991) 1.08
Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol (1991) 1.07
Use of the Edinburgh Postnatal Depression Scale to identify postpartum depression in a clinical setting. J Reprod Med (1994) 1.07
Urinary galactitol in galactosemic patients. Biochem Med (1973) 1.07
Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol (1992) 1.06
Galactosemia: evaluation with MR imaging. Radiology (1992) 1.06
Type IV glycogenosis. Patient with absence of a branching enzyme alpha-1,4-glucan:alpha-1,4-glucan 6-glycosyl transferase. Lab Invest (1968) 1.05
Global Consensus Statement on menopausal hormone therapy. Maturitas (2013) 1.05
Glucose-6-phosphate dehydrogenase variants and their frequency in Guangdong, China. Hum Genet (1988) 1.04
Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. J Clin Endocrinol Metab (2000) 1.03
On the molecular nature of the Duarte variant of galactose-1-phosphate uridyl transferase (GALT). Hum Genet (1994) 1.03
Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycystic ovarian disease. Am J Obstet Gynecol (1980) 1.01
High-frequency pressure-control ventilation with high positive end-expiratory pressure in children with acute respiratory distress syndrome. J Pediatr (1996) 1.01
Semi-micro techniques for the genotyping of galactokinase and galactose-1-phosphate uridyltransferase. Clin Chim Acta (1982) 1.00
Clinical and laboratory predictors of clomiphene response. Fertil Steril (1982) 0.99
Mouse embryo culture as quality control for human in vitro fertilization: the one-cell versus the two-cell model. Fertil Steril (1988) 0.99
Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol (2009) 0.98
Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial. J Clin Endocrinol Metab (1999) 0.98
Childbearing by a galactosemic woman. J Pediatr (1971) 0.98
Extended hemodialysis in children with chronic renal failure. J Pediatr (1968) 0.98
Beta-glucuronidase deficiency. A heterogeneous mucopolysaccharidosis. Am J Dis Child (1985) 0.97
A reevaluation of estrogen status in postmenopausal women who smoke. Am J Obstet Gynecol (1992) 0.97
Triplet pregnancy in a 51-year-old woman after oocyte donation. Am J Obstet Gynecol (1995) 0.97
Recipient's age does not adversely affect pregnancy outcome after oocyte donation. Am J Obstet Gynecol (1995) 0.97
The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women. Obstet Gynecol (1994) 0.97
Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women. Obstet Gynecol (1984) 0.96
A new variant of galactose-1-phosphate uridyltransferase in man: the Los Angeles variant. Ann Hum Genet (1973) 0.96
Consensus conference: Progestagen use in postmenopausal women. Lancet (1988) 0.96
The effect of flexion-extension motion of the lumbar spine on the capacity of the spinal canal. An experimental study. Spine (Phila Pa 1976) (1989) 0.94
Establishment of a nonanonymous donor oocyte program: preliminary experience at the University of Southern California. Fertil Steril (1989) 0.94
Ovarian failure in galactosaemia. Lancet (1979) 0.93
The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women. Fertil Steril (1985) 0.93
Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound. Hum Reprod (1997) 0.93
Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol (2006) 0.93
Association of early beta-human chorionic gonadotrophin values with pregnancy wastage and multiple implantation in a donor oocyte programme. Hum Reprod (1995) 0.93
The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril (1984) 0.93
Do hyperandrogenic women with normal menses have polycystic ovary syndrome? Fertil Steril (1999) 0.93
Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism. Obstet Gynecol (1991) 0.93
Surgical treatment of nonunited fractures of the odontoid process, with special reference to occipitocervical fusion for unreducible atlantoaxial subluxation or instability. Eur Spine J (2000) 0.93
Evidence for altered adipocyte function in polycystic ovary syndrome. Eur J Endocrinol (2005) 0.92
Tyrosinosis. Am J Dis Child (1967) 0.92